文献速递区域麻醉与超声疼痛医学

下肢周围神经阻滞中静脉与神经周围地塞米松比较:荟萃分析

Comparison of intravenous versus perineural dexamethasone as a local anaesthetic adjunct for peripheral nerve blocks in the lower limb: A meta-analysis and systematic review.
PubMed 文献 · Eur J Anaesthesiol · 2024-07-10

该系统综述与荟萃分析比较了下肢周围神经阻滞中静脉注射与神经周围注射地塞米松作为局麻药佐剂的药效学特征。共纳入9项随机对照试验(n=546),主要结局为镇痛持续时间。结果显示神经周围地塞米松较静脉注射延长镇痛持续时间平均差异2.73小时(95%CI 1.07至4.38,P=0.001,I²=87%),证据质量中等,但该差异可能无临床相关性。

要点

  • 神经周围地塞米松较静脉注射延长下肢神经阻滞镇痛时间约2.73小时。
  • 该差异可能无临床相关性,且神经周围给药仍属超说明书用法。
  • 亚组分析显示阻滞部位、局麻药类型或肾上腺素使用不影响结论。

核心结论

  • 中等质量证据支持神经周围地塞米松在延长镇痛持续时间方面优于静脉地塞米松,但差异可能无临床相关性。
  • 神经周围使用地塞米松仍为超说明书用药,临床决策时应予考虑。

研究设计与样本

  • 系统综述与随机对照试验的荟萃分析。
  • 检索Central、Google Scholar、Ovid Embase和Ovid Medline至2023年7月18日。
  • 纳入比较静脉与神经周围地塞米松作为下肢周围神经阻滞局麻药佐剂的随机对照试验。
  • 共纳入9项试验,546例患者。

主要发现

  • 最常见的周围神经阻滞为股神经、坐骨神经和踝部阻滞。
  • 所有试验均使用长效局麻药,多数试验地塞米松剂量为8 mg。
  • 神经周围地塞米松较静脉注射增加镇痛持续时间从19.54小时至22.27小时,平均差异2.73小时(95%CI 1.07至4.38,P=0.001,I²=87%)。
  • 基于阻滞部位、局麻药类型或神经周围肾上腺素使用的亚组分析未显示两组镇痛持续时间有差异。
  • 所有次要结局(疗效和副作用)均未显示差异。

关键数值与推荐

  • 主要结局为镇痛持续时间,所有9项试验(n=546)均报告。
  • 证据质量因严重不一致性评为中等。

临床怎么用

  • 下肢周围神经阻滞时,神经周围地塞米松可较静脉注射 slightly 延长镇痛时间,但差异可能无临床意义。
  • 临床应考虑神经周围给药为超说明书用法。

局限性

  • 证据质量中等,因存在严重不一致性(I²=87%)。
  • 亚组分析未显示特定条件下静脉与神经周围地塞米松的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As a local anaesthetic adjunct, the systemic absorption of perineural dexamethasone in the lower limb could be restricted because of decreased vascularity when compared with the upper limb. OBJECTIVES: To compare the pharmacodynamic characteristics of intravenous and perineural dexamethasone in the lower limb. DESIGN: Systematic review of randomised controlled trials with meta-analysis. DATA SOURCES: Systematic search of Central, Google Scholar, Ovid Embase and Ovid Medline to 18 July 2023. ELIGIBILITY CRITERIA: Randomised controlled trials, which compared the intravenous with perineural administration of dexamethasone as a local anaesthetic adjunct in peripheral nerve blocks for surgery of the lower limb. RESULTS: The most common peripheral nerve blocks were femoral, sciatic and ankle block. The local anaesthetic was long acting in all trials and the dose of dexamethasone was 8 mg in most trials. The primary outcome, the duration of analgesia, was investigated by all nine trials ( n = 546 patients). Overall, compared with intravenous dexamethasone, perineural dexamethasone increased the duration of analgesia from 19.54 to 22.27 h, a mean difference [95% confidence interval (CI) of 2.73 (1.07 to 4.38) h; P = 0.001, I2 = 87]. The quality of evidence was moderate owing to serious inconsistency. However, analysis based on the location of the peripheral nerve block, the type of local anaesthetic or the use of perineural adrenaline showed no difference in duration between intravenous and perineural dexamethasone. No differences were shown for any of the secondary outcomes related to efficacy and side effects. CONCLUSION: In summary, moderate evidence supports the superiority of perineural dexamethasone over intravenous dexamethasone in prolonging the duration of analgesia. However, this difference is unlikely to be clinically relevant. Consideration of the perineural use of dexamethasone should recognise that this route of administration remains off label.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Desai N, Pararajasingham S, Onwochei D, et al. Comparison of intravenous versus perineural dexamethasone as a local anaesthetic adjunct for peripheral nerve blocks in the lower limb: A meta-analysis and systematic review. Eur J Anaesthesiol. 2024. PMID: 38988252. doi:10.1097/EJA.0000000000002038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。